Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-23

FDA Approved: METAXALONE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Metaxalone (METAXALONE) from Amneal Pharmaceuticals LLC under ANDA203399.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metaxalone (metaxalone)

Snippet

SUPPL AP for METAXALONE (METAXALONE)